Prostate Embolization for Massive Benign Prostatic Hypertrophy (BPH)

Status Terminated

Clinical Trial Summary

This is a prospective, open label single center feasibility study to demonstrate basic safety and effectiveness of prostate artery embolization for the treatment of symptomatic benign prostatic Hyperplasia (BPH) in a small series of patients with large (≥90 grams) glands.

Clinical Trial Description

This is a prospective, open labeled, non-randomized, single center feasibility study to evaluate the technical and clinical success of prostatic artery embolization utilizing Embosphere microspheres. At initial consultation patients will be screened to assess the severity of lower urinary tract symptoms (LUTS) related to BPH utilizing the international prostate symptom score (IPSS). After determining eligibility, pre-procedure baseline evaluation will be completed. A baseline prostate ultrasound (TRUS) or MRI will be required to assess prostate mass, and baseline prostate-specific antigen will be measured to help exclude carcinoma and also to follow response to therapy. Patients with suspected malignancy of the prostate will not be enrolled without a negative biopsy finding. Pre- procedure urodynamic studies will be required to assess additional objective measurements and to exclude other causes of LUTS. Cystoscopy will be performed prior to any intervention to help exclude bladder malignancy. If the patient qualifies by the level of symptoms (IPSS score ≥12), prostate size ≥ 90 grams and max urinary flow rate (Qmax) ≤ 12, the patient will be asked to consider enrolling in the study. A study investigator will review the proposed treatment and baseline/follow-up schedule. If the patient agrees to participate in the study, baseline data will be collected on a case report form and an appointment will be made for prostate artery embolization in the interventional radiology department. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02676544
Study type	Interventional
Source	Rhode Island Hospital
Contact
Status	Terminated
Phase	Phase 1/Phase 2
Start date	December 2015
Completion date	June 30, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04856748` - Nomogram to Diagnose Prostatic Inflammation (PIN) in Men With Lower Urinary Tract Symptoms
Completed	`NCT03623880` - Enhancing Behavioral Treatment for Women With Pelvic Floor Disorders	N/A
Enrolling by invitation	`NCT06317116` - Examining the Relationship Between Core Muscles and Bladder Issues in Children
Completed	`NCT03625843` - Mindfulness Exercises to Reduce Anxiety and Pain During Urodynamic Testing	N/A
Recruiting	`NCT05814614` - Bladder Complaints in Parkinson's Disease Effectiveness of Pelvic Floor Muscle Exercises and Electrical Stimulation	N/A
Recruiting	`NCT04288427` - 5-Alpha Reductase 2 as a Marker of Resistance to 5ARI Therapy	N/A
Completed	`NCT03339609` - Uroflow Measurement With Electromyography (EMG) to Identify Lower Urinary Tract Symptoms (LUTS): Conducted on Healthy Children	N/A
Completed	`NCT02330107` - Auriculotherapy on Lower Urinary Tract Symptoms in Elderly Men	N/A
Terminated	`NCT02003742` - Efficacy and Safety of a Single TRUS-guided Intraprostatic Injection of NX-1207 in Patients With LUTS Due to BPH	Phase 3
Terminated	`NCT01003249` - Dysfunctional Voiding and Lower Urinary Tract Symptoms With Baclofen	Phase 4
Completed	`NCT01078545` - Lucrin® Depot Efficacy and Safety Monitoring Study in Patients With Advanced Prostate Cancer and Lower Urinary Tract Symptoms (LUTS)	N/A
Completed	`NCT02074644` - Clinical Trial of Prostatic Arterial Embolization Versus a Sham Procedure to Treat Benign Prostatic Hyperplasia	N/A
Recruiting	`NCT03802851` - HoLEP Prior to Radiation Therapy for Patients With LUTS/Retention and Concurrent Prostate Cancer	N/A
Active, not recruiting	`NCT05415748` - Deprescribing Tamsulosin in Older Men	Phase 4
Recruiting	`NCT05702294` - Electronic Urinary Flowmeter to Improve Accuracy of Bladder Diaries .	N/A
Enrolling by invitation	`NCT05537272` - The Efficacy of Tamsulosin and Tadalafil Compared to Placebo in the Treatment and Prevention of Urinary Disorders After Transperineal Prostate Biopsy	Phase 4
Recruiting	`NCT05826691` - Benign Prostate Surgery and QOL and Sexual Function
Completed	`NCT04104100` - Prevalence and Risk Factor of NP in Women With LUTS
Completed	`NCT04190641` - Single-use Cystoscope System for Direct Visualization of the Urethra and Bladder	N/A
Recruiting	`NCT06012903` - Lower Urinary Tract Symptoms and School Functioning in Children